Prediction of amikacin dose requirements in neutropenic patients with haematological disease

C. S. Zent; R. Allin; P. I. Folb

Prediction of amikacin dose requirements in neutropenic patients with haematological disease

C. S. Zent, R. Allin, P. I. Folb

Hematology

Research output: Contribution to journal › Article › peer-review

Abstract

This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesolf) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. OPT-determined dose adjustment achieved therapeutic drug levels for 80% of the peak and 94% of the trough measurements.

Original language	English (US)
Pages (from-to)	853-854
Number of pages	2
Journal	South African Medical Journal
Volume	83
Issue number	11
State	Published - Dec 1 1993

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{cf25612ca40449269f651cae485530b1,

title = "Prediction of amikacin dose requirements in neutropenic patients with haematological disease",

abstract = "This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesolf) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. OPT-determined dose adjustment achieved therapeutic drug levels for 80% of the peak and 94% of the trough measurements.",

author = "Zent, {C. S.} and R. Allin and Folb, {P. I.}",

year = "1993",

month = dec,

day = "1",

language = "English (US)",

volume = "83",

pages = "853--854",

journal = "South African Medical Journal",

issn = "0256-9574",

publisher = "South African Medical Association",

number = "11",

}

TY - JOUR

T1 - Prediction of amikacin dose requirements in neutropenic patients with haematological disease

AU - Zent, C. S.

AU - Allin, R.

AU - Folb, P. I.

PY - 1993/12/1

Y1 - 1993/12/1

N2 - This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesolf) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. OPT-determined dose adjustment achieved therapeutic drug levels for 80% of the peak and 94% of the trough measurements.

AB - This study reports on the use of an easily applied Bayesian forecasting programme (OPT; Clydesolf) to predict amikacin dose requirements in 10 patients with haematological disease and neutropenic fever. OPT-determined dose adjustment achieved therapeutic drug levels for 80% of the peak and 94% of the trough measurements.

UR - http://www.scopus.com/inward/record.url?scp=0027746177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027746177&partnerID=8YFLogxK

M3 - Article

C2 - 7839219

AN - SCOPUS:0027746177

SN - 0256-9574

VL - 83

SP - 853

EP - 854

JO - South African Medical Journal

JF - South African Medical Journal

IS - 11

ER -

Prediction of amikacin dose requirements in neutropenic patients with haematological disease

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this